5601 - 5650 of 8715 Results
Title
Year
-
OPENTitle: Development of a Positron Emission Tomography Radiotracer for Imaging Elevated Levels of Superoxide in NeuroinflammationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 3Start Page: 578End Page: 586Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.7b00385Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5865080Citation Count: 71
-
OPENTitle: Phenotypic characterization of recessive gene knockout rat models of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 70Issue #:Start Page: 190End Page: 203Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1016/j.nbd.2014.06.009Best OA location URL: https://doi.org/10.1016/j.nbd.2014.06.009Citation Count: 219
-
OPENTitle: Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 5Issue #: 11Start Page: 917End Page: 923Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(06)70579-8Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3636768Citation Count: 88
-
RESTRICTEDTitle: Assessing Tele-Health Outcomes in Multiyear Extensions of Parkinson’s Disease Trials (AT-HOME PD): Initiation of a Long-Term Observational Study (P2.8-011)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p2.8-011Citation Count: 0
-
RESTRICTEDTitle: The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 7_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p06.049Citation Count: 2
-
OPENTitle: The commercial genetic testing landscape for Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 107End Page: 111Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.001Best OA location URL: http://www.prd-journal.com/article/S1353802021003564/pdfCitation Count: 27
-
RESTRICTEDTitle: Rasch analysis of anxiety scales in Parkinson's diseaseJournal Name: Journal of Psychosomatic ResearchPublisher: Elsevier BVVol: 74Issue #: 5Start Page: 414End Page: 419Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jpsychores.2013.02.009Citation Count: 30
-
OPENTitle: A proteogenomic view of Parkinson’s disease causality and heterogeneityJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00461-9Best OA location URL: https://www.nature.com/articles/s41531-023-00461-9.pdfCitation Count: 36
-
RESTRICTEDTitle: Engineering Iron Responses in Mammalian Cells by Signal-Induced Protein ProximityJournal Name: ACS Synthetic BiologyPublisher: American Chemical Society (ACS)Vol: 6Issue #: 6Start Page: 921End Page: 927Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acssynbio.6b00255Citation Count: 13
-
OPENTitle: Comparative sensitivity of the MoCA and Mattis Dementia Rating Scale‐2 in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 2Start Page: 285End Page: 291Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27575Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6532623Citation Count: 19
-
RESTRICTEDTitle: Real-World Experience With VMAT2 InhibitorsJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 42Issue #: 2Start Page: 37End Page: 41Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000326Citation Count: 45
-
OPENTitle: Isogenic human SNCA gene dosage induced pluripotent stem cells to model Parkinson’s diseaseJournal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 60Issue #:Start Page: 102733End Page: 102733Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2022.102733Best OA location URL: https://doi.org/10.1016/j.scr.2022.102733Citation Count: 6
-
OPENTitle: Red hair, MC1R variants, and risk for Parkinson's disease – a meta‐analysisJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 3Start Page: 212End Page: 216Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.381Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.381Citation Count: 26
-
OPENTitle: Data Sharing Goals for Nonprofit Funders of Clinical TrialsJournal Name: Journal of Participatory MedicinePublisher: JMIR Publications Inc.Vol: 13Issue #: 1Start Page: e23011End Page: e23011Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/23011Best OA location URL: https://jopm.jmir.org/2021/1/e23011/PDFCitation Count: 4
-
RESTRICTEDTitle: Personalized prediction of depression in patients with newly diagnosed Parkinson's disease: A prospective cohort studyJournal Name: Journal of Affective DisordersPublisher: Elsevier BVVol: 268Issue #:Start Page: 118End Page: 126Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jad.2020.02.046Citation Count: 23
-
RESTRICTEDTitle: Gba1 E326K renders motor and non-motor symptoms with pathological α-synuclein, tau and glial activationJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 12Start Page: 4072End Page: 4083Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awae222Citation Count: 2
-
RESTRICTEDTitle: Abstract #81: Improving Neurostimulation Clinical Trial Design with Patient Experience DataJournal Name: Brain StimulationPublisher: Elsevier BVVol: 12Issue #: 2Start Page: e28End Page: e29Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2018.12.088Citation Count: 0
-
OPENTitle: LRRK2 inhibition does not impart protection from α-synuclein pathology and neuron death in non-transgenic miceJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-019-0679-5Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-019-0679-5Citation Count: 45
-
RESTRICTEDTitle: Effects of the Serotonin 5-HT1A Receptor Biased Agonists, F13714 and F15599, on Striatal Neurotransmitter Levels Following l-DOPA Administration in Hemi-Parkinsonian RatsJournal Name: Neurochemical ResearchPublisher: Springer Science and Business Media LLCVol: 43Issue #: 5Start Page: 1035End Page: 1046Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11064-018-2514-yCitation Count: 13
- Parkinson's disease-related network topographies characterized with resting state functional MRI2016OPENTitle: Parkinson's disease-related network topographies characterized with resting state functional MRIJournal Name: Human Brain MappingPublisher: WileyVol: 38Issue #: 2Start Page: 617End Page: 630Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/hbm.23260Best OA location URL: http://doi.org/10.1002/hbm.23260Citation Count: 71
- Aging modifies the effect of GCH1 RS11158026 on DAT uptake and Parkinson's disease clinical severity2016OPENTitle: Aging modifies the effect of GCH1 RS11158026 on DAT uptake and Parkinson's disease clinical severityJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 50Issue #:Start Page: 39End Page: 46Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.10.006Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2016.10.006Citation Count: 12
-
RESTRICTEDTitle: Cerebrospinal fluid β‐glucocerebrosidase activity is reduced in parkinson's disease patientsJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 10Start Page: 1423End Page: 1431Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27136Citation Count: 156
-
RESTRICTEDTitle: Clinical genetic testing in Parkinson’s disease should become part of routine patient careJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 8Start Page: 2595End Page: 2597Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1093/brain/awae181Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11292891Citation Count: 4
-
OPENTitle: Dopaminergic Axon Tracts Within a Hyaluronic Acid Hydrogel Encasement to Restore the Nigrostriatal PathwayJournal Name: Advanced Healthcare MaterialsPublisher: WileyVol: 14Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/adhm.202402997Best OA location URL: https://doi.org/10.1002/adhm.202402997Citation Count: 3
-
OPENTitle: Genetic Modifiers of LRRK2 Parkinson's Disease: A Replication Study in Arab‐BerbersJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 4Start Page: 751End Page: 753Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29735Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29735Citation Count: 1
- Microinvasive Probes for Monitoring Electrical and Chemical Neural Activity in Nonhuman Primates2025OPENTitle: Microinvasive Probes for Monitoring Electrical and Chemical Neural Activity in Nonhuman PrimatesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 16Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.5c00071Best OA location URL: https://doi.org/10.1021/acschemneuro.5c00071Citation Count: 0
-
OPENTitle: PINK1 phosphorylates ubiquitin predominantly in astrocytesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-019-0101-9Best OA location URL: https://www.nature.com/articles/s41531-019-0101-9.pdfCitation Count: 40
-
RESTRICTEDTitle: Transplant and risk of Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 149End Page: 155Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.013Citation Count: 6
-
OPENTitle: Paraquat Neurotoxicity is Distinct from that of MPTP and RotenoneJournal Name: Toxicological SciencesPublisher: Oxford University Press (OUP)Vol: 88Issue #: 1Start Page: 193End Page: 201Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/toxsci/kfi304Best OA location URL: https://academic.oup.com/toxsci/article-pdf/88/1/193/4676394/kfi304.pdfCitation Count: 264
-
OPENTitle: Precision medicine for Parkinson’s disease: The subtyping challengeJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.1064057Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.1064057/pdfCitation Count: 8
-
OPENTitle: β-catenin aggregation in models of ALS motor neurons: GSK3β inhibition effect and neuronal differentiationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 130Issue #:Start Page: 104497End Page: 104497Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104497Best OA location URL: https://repositorio.uchile.cl/handle/2250/172258Citation Count: 18
-
OPENTitle: The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α‐Synuclein in PDGBAJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1216End Page: 1228Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28472Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28472Citation Count: 62
-
OPENTitle: Polymerization of Oxidized DJ-1 via Noncovalent and Covalent Binding: Significance of Disulfide Bond FormationJournal Name: ACS OmegaPublisher: American Chemical Society (ACS)Vol: 4Issue #: 6Start Page: 9603End Page: 9614Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1021/acsomega.9b00324Best OA location URL: https://doi.org/10.1021/acsomega.9b00324Citation Count: 3
-
OPENTitle: Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s diseaseJournal Name: Cell Reports MedicinePublisher: Elsevier BVVol: 3Issue #: 6Start Page: 100661End Page: 100661Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.xcrm.2022.100661Best OA location URL: https://doi.org/10.1016/j.xcrm.2022.100661Citation Count: 124
-
OPENTitle: Glucagon‐like Peptides (GLP‐1) Perspectives in Synucleinopathies TreatmentJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 3Start Page: 255End Page: 258Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12611Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12611Citation Count: 7
-
OPENTitle: Pharmacological Inhibition of PTEN Rescues Dopaminergic Neurons by Attenuating Apoptotic and Neuroinflammatory Signaling EventsJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 18Issue #: 3Start Page: 462End Page: 475Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11481-023-10077-8Best OA location URL: https://www.researchsquare.com/article/rs-1785484/latest.pdfCitation Count: 5
-
OPENTitle: Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-022-00554-8Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-022-00554-8Citation Count: 25
-
RESTRICTEDTitle: Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1346End Page: 1359Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29058Citation Count: 17
-
OPENTitle: Functional Brain Networks to Evaluate Treatment Responses in Parkinson's DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 20Issue #: 6Start Page: 1653End Page: 1668Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-023-01433-wBest OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10684458/pdf/13311_2023_Article_1433.pdfCitation Count: 1
-
OPENTitle: A genetic and proteomic comparison of key AD biomarkers across tissuesJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 9Start Page: 6423End Page: 6440Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.14139Best OA location URL: https://doi.org/10.1002/alz.14139Citation Count: 2
-
OPENTitle: Feasibility and utility of a clinician dashboard from wearable and mobile application Parkinson’s disease dataJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 2Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-019-0169-yBest OA location URL: https://www.nature.com/articles/s41746-019-0169-y.pdfCitation Count: 58
- L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progression2019OPENTitle: L-dopa responsiveness in early Parkinson's disease is associated with the rate of motor progressionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 65Issue #:Start Page: 55End Page: 61Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.05.022Best OA location URL: https://www.repository.cam.ac.uk/handle/1810/294951Citation Count: 28
-
OPENTitle: 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson’s disease are associated with LRRC37A/2 expression in astrocytesJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 17Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-022-00551-xBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-022-00551-xCitation Count: 42
-
OPENTitle: Elevated urine BMP phospholipids in LRRK2 and VPS35 mutation carriers with and without Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00482-4Best OA location URL: https://www.nature.com/articles/s41531-023-00482-4.pdfCitation Count: 19
-
OPENTitle: Membrane association but not identity is required for LRRK2 activation and phosphorylation of Rab GTPasesJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 218Issue #: 12Start Page: 4157End Page: 4170Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1083/jcb.201902184Best OA location URL: https://rupress.org/jcb/article-pdf/218/12/4157/1395522/jcb_201902184.pdfCitation Count: 102
-
OPENTitle: The Human Coronavirus Receptor ANPEP (CD13) Is Overexpressed in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 12Start Page: 2134End Page: 2136Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28354Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28354Citation Count: 5
-
OPENTitle: Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4)Journal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 8Issue #: 4Start Page: 517End Page: 527Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-181434Best OA location URL: http://hdl.handle.net/1805/19746Citation Count: 22
-
OPENTitle: NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathyJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 117Issue #: 3Start Page: 1762End Page: 1771Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1909110117Best OA location URL: https://www.pnas.org/content/pnas/117/3/1762.full.pdfCitation Count: 116
- Investigation of serotonergic Parkinson's disease-related covariance pattern using [11C]-DASB/PET2018OPENTitle: Investigation of serotonergic Parkinson's disease-related covariance pattern using [11C]-DASB/PETJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 19Issue #:Start Page: 652End Page: 660Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2018.05.022Best OA location URL: https://doi.org/10.1016/j.nicl.2018.05.022Citation Count: 27
-
OPENTitle: Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson’s DiseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0097-0Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0097-0Citation Count: 73